Fresenius Medical Care AG banner

Fresenius Medical Care AG
XMUN:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
XMUN:FME
Watchlist
Price: 39.85 EUR 0.33%
Market Cap: €23.4B

Fresenius Medical Care AG
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Fresenius Medical Care AG
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Fresenius Medical Care AG
XMUN:FME
Other Current Liabilities
€3.3B
CAGR 3-Years
133%
CAGR 5-Years
73%
CAGR 10-Years
32%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Other Current Liabilities
€3.3B
CAGR 3-Years
133%
CAGR 5-Years
73%
CAGR 10-Years
32%
Fresenius SE & Co KGaA
XETRA:FRE
Other Current Liabilities
€5.7B
CAGR 3-Years
-12%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Vita 34 AG
XETRA:V3V
Other Current Liabilities
€42.9m
CAGR 3-Years
110%
CAGR 5-Years
56%
CAGR 10-Years
32%
E
Euroeyes International Eye Clinic Ltd
HKEX:1846
Other Current Liabilities
HK$67.6m
CAGR 3-Years
-4%
CAGR 5-Years
30%
CAGR 10-Years
N/A
No Stocks Found

Fresenius Medical Care AG
Glance View

Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.

FME Intrinsic Value
49.48 EUR
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Fresenius Medical Care AG's Other Current Liabilities?
Other Current Liabilities
3.3B EUR

Based on the financial report for Dec 31, 2025, Fresenius Medical Care AG's Other Current Liabilities amounts to 3.3B EUR.

What is Fresenius Medical Care AG's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
32%

Over the last year, the Other Current Liabilities growth was -6%. The average annual Other Current Liabilities growth rates for Fresenius Medical Care AG have been 133% over the past three years , 73% over the past five years , and 32% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett